EFFECT OF MATERNAL PARITY AND AGE ON UTERINE FUNDAL HEIGHT DURING PREGNANCY AND THEIR APPLICATION IN PERSONALISED STANDARDS
Introduction: The most available screening method for detecting intrauterine fetal growth restriction is a graph of uterine fundal height (FH) during pregnancy (gravidogram). Сustomized charts with indicators adjusted for ethnicity, age, parity, maternal anthropometric characteristics (height, weight, BMI), parity, pregnancy complications, morbid background, social factors.
Aim: To investigate the effect of maternal characteristics (age and parity) on (FH) during pregnancy, to detect fetal growth restriction.
Materials and Methods: The study design was a single-stage retrospective cross-sectional study. Inclusion criteria for the study were: presence of first trimester ultrasound screening at 10-14 weeks' gestation, uncomplicated pregnancy, singleton pregnancy. Exclusion criteria: multiple pregnancies, breech presentation, malposition (transverse, oblique), fetal weight up to 2500 grams and over 4000 grams, premature birth, hypertensive states, antepartum fetal death, abnormal fetal growth, abundant water, small water, extragenital pathology.
Results: We sampled 3,886 cases of term pregnancies in the cephalic presentation, which ended with a live birth weight of 2,500 to 4,000 grams. When the mean FH values were assessed by age group, significant differences were found at 26, 28, 31-32, 35, and 38 weeks of gestation. It was also found that with an increase in maternal age by 1 year one should expect an increase in FH at weeks 26, 28, 31, 35, 38 and 41 by 0.047 cm; 0.055 cm; 0.049 cm; 0.063 cm; 0.049 cm; 0.057 cm and 0.067 cm. When comparing the mean FH values by maternal parity group, the FH values were found to be higher at 26 to 27, 30 to 35, 37 to 38, and 41 weeks of gestation, and the FH values increased with each successive pregnancy. Using linear regression, it was found that at weeks 31 - 33, 35 weeks of gestation an increase in FH of 0.208 cm; 0.254 cm; 0.154 cm; 0.189 cm should be expected at weeks 38, 40 - 42 weeks, an increase in FH of 0.189 cm; 0.188 cm; 0.576 cm; 7.845 cm should be expected at weeks 38, 40 - 42 weeks.
Conclusions: Maternal age and maternal parity variables are influential factors on uterine fundal height during pregnancy after 31 weeks gestation.
Meruert G. Sharipova1, https://orcid.org/0000-0002-5009-7387
Gulyash A. Tanysheva1, https://orcid.org/0000-0001-9531-5950
Anar S. Kystaubayeva2, https://orcid.org/0000-0002-8712-3307
Aizhan T. Shakhanova1, http://orcid.org/0000-0001-8214-8575
Zaituna G. Khamidullina3, https://orcid.org/0000-0002-5324-8486
Zhanylsyn A. Ryspayeva1, https://orcid.org/0000-0003-1748-6548
Khalida K. Sharipova3, https://orcid.org/0000-0001-5553-8156
1 NJSC «Semey Medical University», Semey, Republic of Kazakhstan;
2 Multi-profile city hospital No. 3 of Astana Akimat, Astana, Republic of Kazakhstan;
3 NJSC «Astana Medical University», Astana, Republic of Kazakhstan
1. Barros F.C. et al. Global report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions // BMC pregnancy and childbirth. 2010. Vol. 10 Suppl 1, P.S3.
2. Carberry A.E. et al. Customised versus population-based growth charts as a screening tool for detecting small for gestational age infants in low-risk pregnant women // The Cochrane database of systematic reviews. 2014. Vol. 2014, №5. P. CD008549.
3. Clausson B. et al. Perinatal outcome in SGA births defined by customised versus population-based birthweight standards // BJOG : an international journal of obstetrics and gynaecology. 2001. Vol. 108, № 8. P. 830–834.
4. Duhig K., Myers J. Detecting fetal growth restriction with customised assessment: Is the jury still out? // PLoS medicine. 2022. Vol. 19, № 6. P. e1004028.
5. Frusca T. et al. Fetal size and growth velocity in chronic hypertension // Pregnancy hypertension. 2017. Vol. 10. P. 101–106.
6. Gardosi J. et al. Association between reduced stillbirth rates in England and regional uptake of accreditation training in customised fetal growth assessment // BMJ Open. 2013. Vol. 3, № 12. P. e003942.
7. Gardosi J. Customized charts and their role in identifying pregnancies at risk because of fetal growth restriction // Journal of obstetrics and gynaecology Canada : JOGC. Elsevier Masson SAS, 2014. Vol. 36, № 5. P. 408–415.
8. Gardosi J., Clausson B., Francis A. The value of customised centiles in assessing perinatal mortality risk associated with parity and maternal size // BJOG : an international journal of obstetrics and gynaecology. 2009. Vol. 116, № 10. P. 1356–1363.
9. Gardosi J. et al. Customized growth charts: rationale, validation and clinical benefits // American journal of obstetrics and gynecology. Elsevier Inc., 2018. Vol. 218, № 2S. P. S609–S618.
10. Gardosi J., Francis A. Controlled trial of fundal height measurement plotted on customised antenatal growth charts // British journal of obstetrics and gynaecology. 1999. Vol. 106, № 4. P. 309–317.
11. Gelbaya T.A., Nardo L.G. Customised fetal growth chart: a systematic review. // Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 2005. Vol. 25, № 5. P. 445–450.
12. Kiserud T. et al. The World Health Organization fetal growth charts: concept, findings, interpretation, and application // American journal of obstetrics and gynecology. 2018. Vol. 218, № 2S. P. S619–S629.
13. Millogo T. et al. Factors associated with fresh stillbirths: A hospital-based, matched, case-control study in Burkina Faso // International Journal of Gynecology & Obstetrics. 2016. Vol. 135, № S1. P. S98–S102.
14. Ravula P.C. et al. Impact of introduction of the growth assessment protocol in a South Indian tertiary hospital on SGA detection, stillbirth rate and neonatal outcome // Journal of perinatal medicine. 2022. Vol. 50, № 6. P. 729–736.
15. Tarca A.L. et al. A new customized fetal growth standard for African American women: the PRB/NICHD Detroit study // American Journal of Obstetrics and Gynecology. 2018. Vol. 218, № 2. P. S679-S691.e4.
16. Williams M. et al. Fetal growth surveillance – Current guidelines, practices and challenges // Ultrasound. 2018. Vol. 26, № 2. P. 69–79.
17. Wallace J.M., Agard J.P., Horgan G.W. A new customised placental weight standard redefines the relationship between maternal obesity and extremes of placental size and is more closely associated with pregnancy complications than an existing population standard // Journal of developmental origins of health and disease. 2020. Vol. 11, № 4. P. 350–359.
Number of Views: 85
Category of articles:
Original articles
Bibliography link
Sharipova М.G., Tanysheva G.A., Kystaubayeva A.S., Shakhanova A.T., Khamidullina Z.G., Ryspayeva Zh.А., Sharipova Kh.K. Effect of maternal parity and age on uterine fundal height during pregnancy and their application in personalised standards // Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 2, pp. 97-104. doi 10.34689/SH.2023.25.2.014Related publications:
ANALYSIS OF CLINICAL AND DEMOGRAPHIC INDICATORS OF PATIENTS WITH PARKINSON'S DISEASE IN THE SOUTHERN REGION OF KAZAKHSTAN
A COMPARATIVE STUDY OF DRUG POLICY REGARDING ORPHAN DISEASES IN THE USA, THE EUROPEAN UNION, AND THE REPUBLIC OF KAZAKHSTAN
MUTATIONS IN CARDIAC ION CHANNEL GENES IN KAZAKHSTANI PATIENTS WITH LONG QT SYNDROME
GENETIC FEATURES OF CONGENITAL DYSFUNCTION OF THE ADRENAL CORTEX CAUSED BY 21-HYDROXYLASE DEFICIENCY IN PERSONS OF KAZAKH NATIONALITY
NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE USING THE EXAMPLE OF AKTOBE PATIENTS